Skip to Content

Virtus LifeSci Biotech Clinical Trls ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit Virtus LifeSci Biotech Clinical Trls ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 22.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Viking Therapeutics Inc

3.16 352,805
Healthcare

Alpine Immune Sciences Inc

2.65 296,579
Healthcare

Cullinan Therapeutics Inc

2.59 289,140
Healthcare

Avidity Biosciences Inc Ordinary Shares

2.54 284,074
Healthcare

Vera Therapeutics Inc Class A

2.40 268,048
Healthcare

Bny Mellon Cash Reserve Usd

2.07 231,644
Cash and Equivalents

Sana Biotechnology Inc Ordinary Shares

1.94 217,140
Healthcare

Spyre Therapeutics Inc

1.87 208,825
Healthcare

Apogee Therapeutics Inc

1.81 202,413
Healthcare

Dyne Therapeutics Inc Ordinary Shares

1.72 192,308
Healthcare